Injectables: The Margin Leader
Neuromodulators and dermal fillers are the margin workhorses. A syringe of Juvéderm or Restylane costs a medspa roughly $40–$60 wholesale (depending on volume rebates through Alle, Aspire, or direct Galderma contracts), and retails for $600–$800. That's a 10–12x markup on product alone. A unit of Botox or Dysport runs $3–$5 per unit at volume, retailing at $12–$15 per unit—again, a 3–5x multiple.
The catch: injectables are labor-light once you've trained staff. A nurse injector can deliver 8–12 patients per day, and the appointment is 15–30 minutes. Overhead per injection is low. Gross margin on injectables often hits 70–75% because you're not paying for expensive capital equipment to depreciate.
The margin erodes only if you're buying small or paying list price. A solo practice buying 5 syringes at a time pays 20–30% more than a 10-location MSO buying 500. This is why group purchasing and manufacturer loyalty programs (Allergan Aesthetics' Aspire, Galderma's Evolus Rewards) matter so much to the bottom line.
Laser and Light-Based Services: Middle Ground
IPL photofacials, laser hair removal, and laser resurfacing sit in the 50–65% margin band. The product cost is nearly zero—you're paying for the energy, which is negligible. The real cost is the device itself.
A solid IPL system (Cutera Excel V, Lumenis M22) runs $80,000–$150,000. A fractional CO₂ laser costs $120,000–$250,000. Over a 5-year useful life, that's $16,000–$50,000 per year in amortized capital cost. If you're doing 30 laser treatments per month, that's $500–$1,600 in device cost per treatment. Add staff time (often a technician at $25–$35/hour for a 30–60 minute session) and your cost of goods sold climbs to 35–50% of revenue.
Laser margins compress further if utilization is poor. A $120,000 laser that sits idle 40% of the time destroys profitability. This is why practices obsess over chair utilization and why laser services are often bundled or promoted aggressively—the fixed cost is so high that volume is the only lever.
Energy Devices: The Capital Trap
RF microneedling, radiofrequency skin tightening, and ultrasound devices (Thermage, Inmode Morpheus8, Candela Profound) command premium pricing—$1,000–$3,000 per session—but carry the heaviest capital burden. A Morpheus8 system costs $200,000+. A Thermage CPT runs $150,000–$200,000. Profound can exceed $300,000.
Gross margins on energy devices often sit at 40–55% because the device amortization is so steep. A $250,000 system over 5 years is $50,000 annually. At 20 treatments per month, that's $2,500 per treatment in capital cost alone. Add staff labor and supplies, and your COGS is 45–60% of the $2,000 treatment fee.
Energy devices are margin-negative in year one. They require patient volume discipline and multi-year payback horizons. Practices that buy them on impulse or without a clear patient-acquisition plan often regret the purchase.
The Margin Drivers You Control
Rebate and loyalty programs: Practices enrolled in Alle or Aspire can save 15–25% on toxin and filler costs versus cash purchases. That directly flows to gross margin.
Utilization: A laser or device sitting idle is pure loss. Practices that hit 70%+ utilization on capital equipment see margins 10–15 points higher than those at 50% utilization.
Staffing model: Practices using nurse injectors or medical aestheticians instead of physicians preserve margin. A nurse injector earning $60,000–$80,000 annually can deliver $400,000–$600,000 in revenue. A physician earning $200,000+ cannot.
Service mix: A practice weighted toward injectables will report higher overall gross margins (65–70%) than one split evenly across injectables, laser, and devices (55–60%).
Pricing power: Markets with high demand and limited supply (affluent urban areas, resort destinations) support 15–25% higher pricing on the same services, directly expanding margin.
What Healthy Looks Like
A well-run medspa should target 60–70% gross margin overall, with injectables pulling the average up and devices pulling it down. Operating margin (after rent, staff salaries, utilities, marketing, and compliance) typically runs 20–35% for mature practices. If you're below 50% gross margin, examine your product costs, pricing, and utilization. If you're above 75%, you may be underpricing or have an unusually favorable cost structure.
